
Neurologist

No OPD information available
Multiple Sclerosis (MS)
Relapsing Multiple Sclerosis (RMS)
CACH Syndrome
Encephalitis
Leukocytosis
Menopause
Progressive Multifocal Leukoencephalopathy
Olga G. Skibina is a female healthcare provider who helps people with different health conditions like Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, Encephalitis, Leukocytosis, Menopause, and Progressive Multifocal Leukoencephalopathy.
Olga G. Skibina uses her special skills and knowledge to treat patients with these conditions. She is very good at understanding and managing these health issues to help her patients feel better.
Olga G. Skibina talks to her patients in a kind and caring way. Patients trust her because she listens to their concerns and explains things clearly. She makes sure her patients understand their treatment plans and feel supported throughout their healthcare journey.
To stay updated with the latest medical knowledge, Olga G. Skibina reads research papers and attends conferences. This helps her provide the best care for her patients based on the most current information available.
Olga G. Skibina works well with other medical professionals. She values teamwork and collaboration to ensure her patients receive comprehensive care. By sharing knowledge and expertise with her colleagues, she can offer the best possible treatment options for her patients.
Olga G. Skibina's work has positively impacted many patients' lives. Her dedication to providing quality care and her expertise in managing complex health conditions have helped her patients live better and healthier lives.
One of Olga G. Skibina's notable publications is "Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis." This study was published in JAMA Neurology on April 14, 2025.
She has also conducted a clinical trial called "A 2-year Prospective Study to Evaluate the Onset of Action of Mavenclad® in Subjects With Highly Active Relapsing Multiple Sclerosis (MAGNIFY)." This trial aimed to improve treatment outcomes for patients with RMS.
Overall, Olga G. Skibina is a dedicated healthcare provider who uses her expertise to improve the lives of her patients with compassion and knowledge.
Enrollment Status: Completed
Published: March 16, 2023
Intervention Type: Drug
Study Drug: Mavenclad®
Study Phase: Phase 4
